Stroke and TIA - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Stroke and TIA

Description:

Stroke and TIA Dr. Tallam Prepared by T. Gifford Definitions Stroke any disease process that interrupts blood flow to the brain Ischemic 80% Hemorrhage 20 ... – PowerPoint PPT presentation

Number of Views:217
Avg rating:3.0/5.0
Slides: 31
Provided by: HMHP3
Learn more at: http://www.sjem.org
Category:
Tags: tia | stroke | trauma | triage

less

Transcript and Presenter's Notes

Title: Stroke and TIA


1
Stroke and TIA
  • Dr. Tallam
  • Prepared by T. Gifford

2
Definitions
  • Stroke any disease process that interrupts
    blood flow to the brain
  • Ischemic 80
  • Hemorrhage 20

3
Ischemic Stroke
  • Thrombotic
  • Most common
  • Atherosclerosis
  • Vasculitis
  • Dissection
  • Polycythemia
  • Hypercoagulable
  • Develop over minutes to hours
  • Often previous TIA in same distribution
  • Embolic
  • Intravascular material is released occluding
    vessel downstream
  • No underlying vascular disease at site
  • Valvular vegetations
  • Mural thrombi
  • Cardiac tumors
  • Fat embolism
  • Drug injection

4
Ischemic Stroke
  • Hypoperfusion
  • Usually from cardiac failure
  • Less common
  • Symptoms wax and wane as blood pressure changes.

5
Hemorrhagic Stroke
  • Types
  • Intracranial hemorrhage (ICH)
  • Bleeding directly into parenchyma from weakened
    small arterioles
  • Non traumatic subarachnoid (SAH)
  • Blood leaks from cerebral vessel into
    subarachnoid space
  • Berry aneurysm rupture

6
Clinical
  • History
  • HTN
  • CAD
  • DM
  • A-fib
  • Valve repair
  • Recent MI
  • Recent TIA

7
Physical Exam
  • Febrile R/O infection
  • Skin
  • Janeway lesions
  • Osler nodes
  • Bleeding dyscrasias
  • Cardio/Lungs
  • Rales
  • S3
  • Carotid bruit

8
Physical Exam
  • Fundoscopic exam
  • Papilledema
  • Mass lesion
  • Cerebral vein thrombosis
  • HTN crisis
  • Pre-retinal hemorrhage
  • SAH

9
Neurological Exam
  • Goal
  • Localize CNS lesion
  • NIH Scale

10
Neurological Exam
  • Level of consciousness
  • Visual assessment
  • Motor function
  • Cerebellar function
  • Sensation and neglect
  • Language
  • Cranial nerves

11
Stroke Syndromes
  • TIA
  • Neurological deficit that resolves within 24
    hours (some say 30min)

12
Ischemic Stroke Syndromes
  • Anterior cerebral artery infarction
  • Contralateral leg weakness greater than arm
    weakness
  • Mild cortical sensory deficits

13
Ischemic Stroke Syndromes
  • Middle cerebral artery infarction
  • Contrlateral weakness and numbness
  • Variably affecting the face and arm greater than
    leg
  • If dominant hemisphere aphasia often present
  • Neglect / inattention non dominant hemisphere
  • Homonymous hemianopsia / gaze toward infarct
    common

14
Ischemic Stroke Syndromes
  • Posterior cerebral artery infarction
  • May be unaware of symptoms
  • Minimal motor involvement
  • Light touch / pin prick reduced
  • Vertibrobasilar syndrome
  • Posterior circulation compromised
  • Crossed neurological defecits
  • Ipsilateral CN deficit, contralateral motor
    weakness
  • Dizziness, vertigo, diploplia
  • Wallenberg syndrome
  • Ipsilateral loss facial pain and temp with
    contralateral in body

15
Ischemic Stroke Syndromes
  • Basilar artery syndrome
  • Quadraplegia
  • Coma
  • Locked in syndrome
  • Lesion in pontine tectum with complete muscle
    paralysis with exception of upward gaze
  • Cerebellar infarction
  • drop attack, vertigo, H/A, N/V, neck pain
  • After 6-12 hours cerebral edema develops
  • MRI / MRA surgical decompression

16
Ischemic Stroke Syndromes
  • Lacunar infarct
  • Pure motor or sensory deficits caused by infarct
    of small penetrating arteries
  • Associated with chronic hypertension
  • Primarily in pons and basal ganglia
  • Arterial dissection
  • Associated with trauma / turning of head or
    spontaneously
  • Hypertension is risk factor
  • Severe neck pain, H/A hours to days before
    symptoms

17
Hemorrhagic StrokeSyndromes
  • ICH
  • Clinically indistinguishable from infarction
  • H/A, N/V proceed deficit.
  • Cerebellar hemorrhage
  • Sudden onset dizziness, vomiting, truncal ataxia,
    inability to walk
  • May be associated with gaze palsy and stupor

18
Hemorrhagic Stroke Syndromes
  • SAH
  • Severe constant H/A often in occipital or nuchal
    area
  • Vomiting common, decrease LOC
  • Sentinal hemorrhage
  • Sudden presentation

19
Diagnosis
  • Education
  • Patients (911 usage)
  • EMS careful ID of onset if possible
  • Triage
  • Antithrombolysis screening

20
Diagnosis
  • Tests
  • Emergent non contrast CT
  • Ischemic strokes need at least 6 hours before
    visibility
  • Identifies all parenchymal bleeds gt1cm and 95 of
    SAH (if done within 12 hours)
  • Lumbar puncture
  • If high suspicion of SAH persists after CT
  • EKG
  • Identify a-fib or AMI
  • Labs
  • MRI / MRA
  • Carotid ultrasound

21
Differentials
  • Epidural / Subdural
  • Hyponatremia
  • Postictal paralysis (Todd)
  • HTN encephalopathy
  • Brain tumor / Abscess
  • Meningitis / encephalitis
  • Hyperosmotic coma
  • Wernicke encephalopathy
  • Labyrinthitis
  • Drug toxicity
  • Bell palsy
  • Complicated migraine
  • Meniere disease
  • Demyelinating disease

22
Treatment
  • General
  • ABCs, O2, Monitor
  • HOB elevated
  • Cardiac monitor
  • IV access
  • Judicious fluids
  • Refrain from glucose containing fluids (no
    evidence to support)
  • Seizures
  • Treat seizure with ativan and load with
    fosphenytoin.
  • No prophylaxis

23
Treatment
  • Hypertension
  • Consider persistent elevation gt220 systolic for
    treatment
  • Use easily titratable meds
  • Lebatelol
  • Enalaprit
  • NTG paste
  • May need to treat to qualify for tPA

24
Thrombolysis
  • NINDS study
  • Milticenter, randomized, double-blind, placebo
  • 624 patients
  • At 3 months, rtPA group was 30 more likely to
    have minimal or no disability
  • Symptomatic ICH 6.4 compared to 0.6
  • Other studies have had variable results
  • FDA approved for ischemic stroke in 1996
  • Supported by
  • AHA
  • AAN
  • ACEP

25
Thrombolysis
  • Pre Screen
  • tPa Dose
  • 0.9mg/kg, max 90 mg
  • 10 as bolus
  • Remainder over 60 min
  • No ASA or Heparin in 24 hours after
    administration

26
Treatment in tPA Non-Candidates
  • Goal of secondary stroke prevention
  • Antiplatelets
  • ASA 50-300mg daily
  • Reduced risk by 20-25
  • Dipyridamole 200 mg BID
  • Reduced risk by 15 alone
  • Dipyridamole ASA
  • Reduced risk by 37
  • Plavix 75 mg daily
  • Marginally superior to ASA

27
Treatment in tPA Non-Candidates
  • Goal of secondary stroke prevention
  • Anticoagulants
  • UFH efficacy lacking, possible harmful
  • Increased rate ICH
  • Decreased rate recurrent ischemic stroke
  • The use of UFH, LMWH or heparinoids is therefore
    not recommended for stroke or TIA treatment based
    on current evidence
  • Warfarin is indicated for those with A-fib and
    TIA

28
Treatment
  • Cerebellar infarction
  • Early neurosurgical consultation
  • TIA
  • New onset
  • Admit for evaluation of sources of emboli or
    stenosis
  • Some recommend UFH when
  • Known high grade stenosis
  • Cardioembolic source (except infective
    endocarditis)
  • Crescendo TIAs
  • TIAs despite antiplatelets
  • Early carotid endarterectomy if gt70 stenosis

29
Treatment
  • ICH
  • Treat severe hypertension
  • SBP gt220
  • DBP gt120
  • Slow reduction unless cardiac failure or
    dissection
  • Elevate HOB 30 degrees
  • Increased ICP
  • Hyperventilation
  • Paco2 target 30-35
  • Osmotherapy
  • Mannitol 1.0 g/kg IV
  • Target lt310 mOsm/kg
  • Lasix 10 mg IV
  • Consider seizure prophylaxis
  • Surgical consultation

30
Treatment
  • SAH
  • Rebleed and vasospasm are major complications
  • Keep SBP lt 160
  • Nimodipine 60 mg q 6 hr
  • Reduces incidence and severity of vasospasm
  • Prophylactic phenytoin
  • Antiemetics
  • Surgical consultation
Write a Comment
User Comments (0)
About PowerShow.com